Bison Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,785
Closed -$2.49M 348
2024
Q3
$2.49M Sell
4,785
-202
-4% -$108K 0.4% 61
2024
Q2
$2.59M Hold
4,987
0.42% 61
2024
Q1
$2.59M Sell
4,987
-9
-0.2% -$4.48K 0.42% 61
2023
Q4
$2.36M Sell
4,996
-550
-10% -$254K 0.42% 58
2023
Q3
$2.41M Sell
5,546
-704
-11% -$319K 0.47% 50
2023
Q2
$2.78M Buy
6,250
+410
+7% +$189K 0.52% 46
2023
Q1
$2.67M Sell
5,840
-44
-0.7% -$20.9K 0.83% 26
2022
Q4
$2.88M Sell
5,884
-600
-9% -$305K 0.92% 22
2022
Q3
$2.94M Buy
6,484
+5,786
+829% +$2.77M 1.16% 12
2022
Q2
$337K Buy
698
+165
+31% +$81.6K 0.19% 136
2022
Q1
$262K Buy
+533
New +$244K 0.13% 175

Other funds holding ELV

Bison Wealth's ELV Position: Q4 2024 in Review

Bison Wealth sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 4,785 shares — an estimated $2.49M sold.

Bison Wealth first reported a position in ELV in Q1 2022 and held it in 11 quarters. The position peaked at $2.94M in Q3 2022. 1,603 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Bison Wealth reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Bison Wealth sold 4,785 Elevance Health shares in Q4 2024, an estimated $2.49M.
  • Bison Wealth first reported a position in Elevance Health in Q1 2022 and held it in 11 quarters.
  • Bison Wealth's Elevance Health position peaked at $2.94M in Q3 2022.
  • 1,603 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Bison Wealth's 13F filing for Q4 2024, filed 14 Feb 2025.